We present the clinical characteristics, outcomes, and risk factors for coronavirus disease 2019 (COVID-19) in allogeneic hematopoietic stem cell transplantation recipients during the Omicron wave. The recipients exhibited a low COVID-19–related mortality rate and high moderate-to-severe and prolonged disease incidence.
All Keywords
【저자키워드】 COVID-19, allogeneic hematopoietic stem cell transplantation, Anti-thymocyte globulin, omicron wave, early post-transplantation,
【저자키워드】 COVID-19, allogeneic hematopoietic stem cell transplantation, Anti-thymocyte globulin, omicron wave, early post-transplantation,